Trial intelligence / Profile preview

PRESAGE: Prevention of AF in Lung Cancer Surgery

NCT01281787Phase 3Completed

Sponsor
European Institute of Oncology
Start
Apr 2008
Primary completion
Jun 2013
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of metoprolol, losartan in Atrial fibrillation (AFib), sponsored by European Institute of Oncology. Started Apr 2008; status: completed.

02

Drugs

metoprolollosartan
03

Conditions

Atrial fibrillation (AFib)

Beyond the preview

Go deeper on NCT01281787.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01281787.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call